본문 바로가기
KERD
논문KCI 등재

중국의 COVID-19 대응을 위한 중의약 활용

Utilization of Traditional Chinese Medicine for COVID-19 in China

1

조회

0

다운로드

1

인용

0

참고문헌

키워드

주제분류한의학

초록

Objectives : The objectives of this study were to investigate why and how China used traditional Chinese medicine as a response to COVID-19 and how its performance was achieved, and to explore ways to utilize traditional Korean medicine in Korea. Methods : We examined the information through government data and media articles. China's COVID-19 progress and policy response were reviewed and compared with Korea. Based on this, the characteristics of traditional Chinese medicine response in China were identified. Results : Based on legal basis, China makes the overall use of traditional Chinese medicines to respond to COVID-19. Traditional Chinese medicine has been applied to health insurance, the licensing regulations have been eased, and traditional Chinese medical specialists were dispatched. The medical care guidelines were developed and R&D were carried out. In addition, policies related to traditional Chinese medicine included policies for preventive treatment, the combination of Chinese and Western medicine, and telemedicine. Conclusions : Traditional Chinese medicine response to COVID-19 was included within the overall national quarantine policy, providing medical services for the mild stage. In addition, R&D was conducted to establish a basis for the utilization of traditional Chinese medicines. Traditional Korean medicine also needs to be prepared so that it can be used as a complement to the response of communicable diseases.

Abstract

Objectives : The objectives of this study were to investigate why and how China used traditional Chinese medicine as a response to COVID-19 and how its performance was achieved, and to explore ways to utilize traditional Korean medicine in Korea. Methods : We examined the information through government data and media articles. China's COVID-19 progress and policy response were reviewed and compared with Korea. Based on this, the characteristics of traditional Chinese medicine response in China were identified. Results : Based on legal basis, China makes the overall use of traditional Chinese medicines to respond to COVID-19. Traditional Chinese medicine has been applied to health insurance, the licensing regulations have been eased, and traditional Chinese medical specialists were dispatched. The medical care guidelines were developed and R&D were carried out. In addition, policies related to traditional Chinese medicine included policies for preventive treatment, the combination of Chinese and Western medicine, and telemedicine. Conclusions : Traditional Chinese medicine response to COVID-19 was included within the overall national quarantine policy, providing medical services for the mild stage. In addition, R&D was conducted to establish a basis for the utilization of traditional Chinese medicines. Traditional Korean medicine also needs to be prepared so that it can be used as a complement to the response of communicable diseases.

참고문헌 (65)

  1. "Coronavirus disease 2019(COVID-19): situation report – 182"[URL]
  2. "Regular briefing: COVID-19 domestic outbreak status" (2020)[URL]
  3. Ying Liu, "The reproductive number of COVID-19 is higher compared to SARS coronavirus", Journal of Travel Medicine, 27(2) (2020)
  4. "Summary table of SARS cases by country, 1 November 2002- 7 August 2003"[URL]
  5. 장인수, "중증급성호흡기증후군(SARS)의 한약 치료에 관련된 WHO 임상논문 보고에 대한 개관", 대한한방내과학회지, 26(2), pp.440~452 (2005), 대한한방내과학회
  6. SARS-Clinical trials on treatment using a combination of Traditional Chinese medicine and Western medicine, "World Health Organization", ~ (2004)
  7. COVID-19 Response Guidelines (for local governments)-the 7th version, "Korea Centers for Disease Control and Prevention", ~ (2020)
  8. "Fifth, self-isolation death...More than 2,000people are waiting to be hospitalized"[URL]
  9. "Coronavirus disease 2019(COVID-19): situation report – 1"[URL]
  10. "Operation of the Korean medicine TF to respond to COVID-19"[URL]
  11. "Regular briefing: COVID-19 domestic outbreak status(2020.02.24.)" (2020)[URL]
  12. "Announcement of the Korean medicine recommendations on treatment of COVID-19(the first version)"[URL]
  13. "Announcement of the first version of Oriental Medicice Clinical Practice Guideline by the Korean Association of Traditional Pulmonary Medicine"[URL]
  14. "Korean medicine doctors came forward to overcome COVID-19 – free presciption after telemedicine"[URL]
  15. "Announcement of the National Health Commission of the People’s Republic of China"[URL]
  16. "The gorvernment demands intervention in the treatment of COVID-19"[URL]
  17. "Guideline on diagnosis and treatment of COVID-19 (4th edition)"[URL]
  18. "Notice about launch of online services for the epidemic prevention of the Hubei province"[URL]
  19. "All-out response based on community response system"[URL]
  20. "Infectious Disease Crisis Alert Level Upgrades to “Orange (Level 3)”"[URL]
  21. "Approving emergency use of new COVID-19 diagnostic reagents"[URL]
  22. "Counseling and prescription by telephone due to mild cold symptoms are temporary allowed"[URL]
  23. "Briefing of the Central Disaster and Safety Countermeasures Headquarters on COVID-19 response"[URL]
  24. "The government will take an active response so that people will not be treated unfairly"[URL]
  25. "The Association of Korean Medicine publishes the guideline for telemedicine of Korean medicine"[URL]
  26. "Guideline on diagnosis and treatment of COVID-19 (1st edition)"[URL]
  27. "Ministry of Science and Technology of the People’s Republic of China: 16emergency research projects were launched and some drugs were initially selected"[URL]
  28. "Notice about good health coverage for COVID-19"[URL]
  29. "Notice about regulation of COVID-19 drug clinical research in medical institutions"[URL]
  30. "Nursing Standards for Medium and Critical Patients of COVID-19"[URL]
  31. "Plan of COVID-19 control and preventive(6th edition)"[URL]
  32. "Guidance on the Rehabilitation of Chinese medicine for COVID-19 recovery period"[URL]
  33. "Obtain approval for clinical trials of 化湿败毒颗粒"[URL]
  34. "Law of the People’s Republic of China on Traditional Chinese Medicine"[URL]
  35. "Law of the People’s Republic of China on Prevention and Treatment of Infectious Diseases"[URL]
  36. "A press conference on February 20, 2020"[URL]
  37. "Chinese Clinical Trial Registry"[URL]
  38. "Two cases of herbal medicine’s hospital preparations for COVID-19 prevention and treatment have been approved in Sanxi Province"[URL]
  39. "Hospital preparation for COVID-19 of Pneumonia No. 1 and Qianli Pneumonia No. 1 have been approved in Hubei Province"[URL]
  40. "Hubei’s first herbal medicine preparation for pneumonia caused by the new coronavirus infection"[URL]
  41. "Preparing for approval of seven medical institutions in Yunnan Province"[URL]
  42. "Tujie Quwen Granules has passed an emergency approval and application for herbal medicine from Guangdong Medical Center"[URL]
  43. "Sichuan approves the use of three kinds of hospital preparations in 205 designated hospitals in the province"[URL]
  44. "When the country is in trouble, the Chinese medicine doctors are responsible and they rush to the front"[URL]
  45. "Local science and technology departments take active action to provide scientific and technical support for the prevention and control of infectious diseases"[URL]
  46. "Step-by-step progress has been made in the screening of effective herbal medicine prescriptions, and clinical observations in the experimental provinces shows that the total effectiveness of the treatment for clearing lung can be more than 90"[URL]
  47. "Tianjin University of Traditional Chinese Medicine actively carried out the research and clinical application of TCM to control COVID-19"[URL]
  48. "Patent information on Chinese Medicine for the prevention and control of COVID-19"[URL]
  49. "National Administration of Traditional Chinese Medicine"[URL]
  50. "Notice about Chinese medicine prevention of COVID-19"[URL]
  51. "Notice about combination Chinese and Western medicine for COVID-19"[URL]
  52. "Notice of establishment of Chinese and Western medicine cooperative system in preventive treatment of infectious diseases, such as COVID-19"[URL]
  53. "Notice about strengthening information for support of Chinese medicines prevention for COVID-19"[URL]
  54. "China unveils targets for 2015: Li Keqiang’s speech as it happened"[URL]
  55. "National Administration of Traditional Chinese Medicine: Chinese medicine accounted for 85.2% of Chinese national treatment"[URL]
  56. Korea Institute of Oriental Medicine, "Chinese medicine trends related to COVID-19 in China", ~ (2020)
  57. Murthy S, "Care for Critically Ill Patients With COVID-19", JAMA, 323(15), pp.1499~1500 (2020)
  58. Greenhalgh T, "Covid-19:a remote assessment in primary care", BMJ, pp.368~ (2020)
  59. Shen Ai-ming, "TCM Theory analysis of Qing-Fei-Pai-Du-Tang in treating COVID-19", Liaoning Journal of Traditional Chinese Medicine (2020)
  60. 路志正, "“清肺排毒汤”彰显中医药抗疫疗效与自信", Journal of Traditional Chinese Medicine (2020)
  61. Lin Ang, "Herbal medicine and pattern identification for treating COVID-19: a rapid review of guidelines", Integrative Medicine Research, 9(2), pp.1~14 (2020), 한국한의학연구원[DOI]
  62. National Health Commission of the People’s Republic of China, "Notice on the issuance of the new 7th version of the COVID-19 Diagnosis and Treatment Guideline", ~ (2020)
  63. Gras G, "Use of telemedicine in the management of infectious diseases", Médecine et maladies infectieuses, 48, pp.231~237 (2018)
  64. Burnham JP, "Telemedicine Infectious Diseases Consultations and Clinical Outcomes: A Systematic Review", Open Forum Infect Dis, 6(12), pp.ofz517~ (2019)
  65. 박선철, "Mental Health Care Measures in Response to the 2019 Novel Coronavirus Outbreak in Korea", PSYCHIATRY INVESTIGATION, 17(2), pp.85~86 (2020), 대한신경정신의학회[DOI]

관련 논문AI추천

이 간행물의 다른 논문 (8건)